Why the study?
The direct impact of transesophageal echocardiography (TEE) on the effectiveness and safety of transvenous lead extraction (TLE) had not yet been documented.
Does continuous transesophageal echocardiography monitoring improve procedure effectiveness and survival in patients undergoing transvenous lead extraction?
Does continuous transesophageal echocardiography monitoring improve procedure effectiveness and survival in patients undergoing transvenous lead extraction?
Continuous TEE monitoring during transvenous lead extraction is associated with higher procedural success and fewer severe complications compared to pre- and post-procedural TEE only.
Continuous TEE monitoring during TLE was associated with higher complete success and fewer major complications than predicted; leaves open whether routine use improves outcomes prospectively.
Background: Transesophageal echocardiography (TEE) is a valuable tool for monitoring the patient during transvenous lead extraction (TLE), but the direct impact of TEE on the effectiveness and safety of TLE has not yet been documented. Methods: The effectiveness of TLE and short-term survival were compared between two groups of patients: 2106 patients in whom TEE was performed before and after TLE and 1079 individuals in whom continuous TEE monitoring was used. The procedure-related risk of major complications was assessed using a predictive SAFeTY TLE score. Results: The patients monitored by TEE were characterized by older age, more comorbidities and higher SAFeTY TLE scores (6.143 ± 4.395 vs. 5.593 ± 4.127; p = 0.004). Complete procedural success was significantly higher in the TEE-guided group (97.683% vs. 95.442%, p < 0.01). The rate of serious complications in the TEE-guided group was lower than the predictive SAFeTY TLE score—a reduction of 28.75% (p < 0.05). Periprocedural mortality in the TEE-guided and non-TEE-guided groups was zero vs. six deaths (p = 0.186). Short-term survival was comparable between the groups. Conclusions: Transesophageal echocardiography as a monitoring tool during transvenous lead extraction provides valuable results—higher rates of complete procedural success and a reduced risk of the most severe complications, thus preventing periprocedural deaths.
No takes yet. Share an insight, caveat, or question.
Nowosielecka et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: